{"action":"elsewhere","city":"CHIYODA KU","companyRegistrationNumber":null,"conformityFlag":"NON_CONFORMING","country":"JP","createdAt":null,"entityCategory":"GENERAL","entityStatus":"ACTIVE","entitySubCategory":null,"expirationReason":null,"expiredAt":null,"family":{"children":[],"childrenTotal":0,"exceptions":[],"parents":[{"active":true,"country":"US","legalName":"Sucampo Pharmaceuticals, Inc.","lei":"549300YPLK5FSJFMAH24","relationshipTypes":["IS_DIRECTLY_CONSOLIDATED_BY"]},{"active":true,"country":"IE","legalName":"MALLINCKRODT PUBLIC LIMITED COMPANY","lei":"549300LMDE3RUP8Z3L60","relationshipTypes":["IS_ULTIMATELY_CONSOLIDATED_BY"]}]},"headquartersAddress":"675 MCDONNELL BOULEVARD","headquartersCity":"HAZELWOOD","headquartersCountry":"US","headquartersPostalCode":"63042","headquartersRegion":"US-MO","lastUpdatedAt":"2023-07-31T17:11:36.903Z","legalAddress":"1-7, UCHISAIWAICHO 1-CHOME","legalFormAbbreviation":"合","legalFormCode":"7QQ0","legalFormName":"合同会社","legalJurisdiction":"JP","legalName":"SUCAMPO PHARMA, LLC","lei":"549300QZDP780EI1IT13","managingLou":"213800WAVVOPS85N2205","managingLouName":"London Stock Exchange","managingLouWebsite":"https://www.lseg.com/LEI","nextRenewalAt":"2022-03-01T22:28:00Z","otherLegalForm":null,"postalCode":"100-6213","region":"JP-13","registeredAt":"2018-04-13T15:30:00Z","registrationAuthorityId":"RA999999","registrationAuthorityName":"No Registration Authority available","registrationAuthorityWebsite":null,"registrationNumber":null,"registrationNumberFormatted":null,"registrationStatus":"LAPSED","served":false,"successorLeis":[],"validationAuthorityEntityId":null,"validationAuthorityId":"RA999999","validationAuthorityName":"No Registration Authority available","validationSources":"ENTITY_SUPPLIED_ONLY"}